How are genetic alterations coordinated? Colon cancer;Comment se coordonnent les alterations genetiques? Le cancer colique

Hepato-Gastro

Volumn 4, Issue 2 SUPPL., 1997, Pages 76-84

  Laurent Puig, Pierre ^a  

^a INSTITUT CURIE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSFORMING GROWTH FACTOR BETA;

CARCINOGENESIS; CELL PROLIFERATION; CHROMOSOME 17; CHROMOSOME 18Q; CHROMOSOME 5; COLON CANCER; CONFERENCE PAPER; GENE LOCATION; GENE MUTATION; HETEROZYGOSITY LOSS; HISTOLOGY; HUMAN; ONCOGENE K RAS;

EID: 0030888857     PISSN: 12537020     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (74)

1. Vogelstein B, Fearon ER, Kern SE, Halmilton SR, Preisinger AC, Nakamura Y, White R, Allelotype of colorectal carcinomas. Science 1989 , 244 : 207-11.
2. Delattre O, Olschwang S, Law DJ, Melot T, Remvikos Y, Salmon RJ, et al. Multiple genetic alterations in distal and proximal colorectal cancer. Lancet 1989 ; 2 : 353-6.
3. Fishel R, Lescoe MK, Rao MR, Copeland NG, Jenkins NA, Garber J, et al. The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer Cell 1993 , 75 . 1027-38
4. Bronner CE, Baker SM, Morrison PT, Warren G, Smith LG, Lescoe MK, et al. Mutation in the DNA mismatch repair gene homologue hMLH1 is associated with hereditary non-polyposis colon cancer. Nature 1994 ; 368 : 258-61
5. Nicolaides NC, Papadopoulos N, Liu B, Wei YF, Carter KC, Ruben SM, et al Mutations of two PMS homologues in hereditary nonpolyposis colon cancer Nature 1994 ; 371 : 75-80
6. Palombo F, Gallinari P, Iaccarino I, Lettieri T, Hughes M, D'Arrigo A, et al. GTBP, a 160-kilodalton protein essential for mismatch-binding activity in human cells Science 1995 ; 268 : 1912-4.
7. Malkhosyan S, Rampino N, Yamamoto H, Perrucho M Frameshift mutator mutation. Nature 1996 ; 382 : 499-500.
8. Leach FS, Nicolaides NC, Papadopoulos N, Liu B, Jen J, Parsons R, et al Mutations of a mutS homolog in hereditary nonpolyposis colorectal cancer Cell 1993; 75: 1215-25.
9. Papadopoulos N, Nicolaides NC, Liu B, Parsons R, Lengauer C, Palombo F, et al. Mutations of GTBP in genetically unstable cells Science 1995 , 268 : 1915-7.
10. Liu B, Nicolaides NC, Markowitz S, Willson JKV, Parsons RE, Jen J, et al Mismatch repair gene in sporadic colorectal cancers with microsatellite instability. Nature Genet 1995 , 9 : 48-55.
11. Borresen AL, Lothe RA, Meling GI, Lystad S, Morrison P, Upford J, et al Somatic mutations in the hMSH2 gene in microsatellite unstable colorectal carcinomas. Hum Mol Genet 1995 ; 4 : 2065-72
12. Moslein G, Tester DJ, Undor NM, Honchel R, Cunningham JM, French AJ, et al. Microsatellite instability and mutation analysis of hMSH2 and hMLH1 in patients with sporadic, familial and hereditary cancer. Hum Mol Genet 1996 , 9 : 1245-52.
13. Remvikos Y, Vogt N, Muleris M, Salmon RJ, Malfoy B, Dutrillaux B. DNA-repeat instability is associated with colorectal cancers presenting minimal chromosome rearrangements Genes Chromosom Cancer 1995, 12 : 272-6.
14. Thibodeau SN, Bren G, Schaid D. Microsatellite instability in cancer of the proximol colon. Science 1993 ; 260 : 816-9.
15. Konishi M, Kikuchi-Yanoshita R, Tanaka K, Muraoka M, Onda A, Okumura Y, et al. Molecular nature of colon tumors in hereditary nonpolyposis colon cancer, familial polyposis, and sporadic colon cancer. Gastroenterology 1996 ; 111 : 307-17.
16. Bedenne L, Faivre J, Boutron MC, Piard F, Cauvin JM, Hillon P. Adenoma-carcinoma sequence or de novo carcinogenesis ? A study of adenomatous remnants in a population based series of large bowel cancer. Cancer 1992 ; 69 : 883-8.
17. Vogelstein B, Fearon ER, Hamilton SR Kem SE, Preisinger AC, Leppert M, et al. Genetic alterations during colorectal-tumor development N Engl J Med 1988 ; 319 525-32.
18. Boland CR, Sato J, Appelman HD, Bresalier RS, Feinberg AP. Microallelotyping defines the sequence and tempo of allelic losses at tumour suppressor gene loci during colorectal cancer progression. Nature Medicine 1995 ; 1 : 902-9.
19. Miyaki M, Konishi M, Kikuchi-Yanoshita R, Enomoto M, Igari T, Tanaka K, et al. Characteristics of somatic mutation of the adenomatous polyposis coli gene in colorectal tumors. Cancer Res 1994 ; 54 : 3011-20.
20. Smith KJ, Johnson KA, Bryan TM, Hill DE, Markowitz S, Willson JK, et al. The APC product in normal and tumor cells. Proc Natl Acad Sci USA 1993 ; 90 : 2846-50.
21. Jen J, Powell SM, Papadopoulos N, Smith KJ, Hamilton SR, Vogelstein B, Kinzler KW. Molecular determinants of dysplosia in colorectal lesions. Cancer Res 1994 ; 54 : 5523-6.
22. Miyashiro I, Senda T, Matsumine A, Baeg GH, Kuroda T, Shimano T, et al. Sub-cellular localization of the APC protein : immunodelectron microscopic study of the association of the APC protein with the catenin Oncogene 1995, 11 . 89-96
23. Su LK, Vogelstein B, Kinzler KW. Association of the APC tumor suppressor protein with catenins. Science 1993 ; 262 : 1734-7.
24. Rubinfield B, Souza B, Albert I, Muller O, Chamberlain SH, Masiarz FR, et al Association of the APC gene product with beta-catenin Science 1993 ; 262 : 1731-4
25. Su LK, Burell M, Hill DE, Gyuris J, Brent R, Wiltshire R, et al. APC binds to the novel protein EB1. Cancer Res 1995; 55 : 2972-7
26. Motsumine A, Ogai A, Senda T, Okumura N, Satoh K, Baeg GH, et al. Binding of the APC to the human homolog of the drosophilia dics large tumor suppressor protein. Science 1996 ; 272 : 1020-3
27. Rubinfield B, Albert A, Porfiri E, Fiol C, Munemitsu S, Polakis P Binding of the GSK3-beta to the APC-beta-catenin complex and regulation of complex assembly. Science 1996 ; 272 1023-5.
28. Smith KJ, Levy DB, Maupin P, Pollard TD, Vogelstein B, Kinzler KW. Wild type but not mutant APC associates with the microtubule cytoskeleton Cancer Res 1994 ; 54 . 3672-5.
29. Nusse R, Varmus HE. Wnt genes. Cell 1992, 69 : 1073-87.
30. Behrens J, von Kries JP, Kuhl M, Bruhn L, Wedlich D, Grosschedi R, Birchmeier W Functional interaction of betacotenin with the transcription factor LEF-1. Nature 1996 ; 382 : 638-42.
31. Whitehead I, Kirk H, Kay R. Expression cloning of oncogenes by retroviral transfer of c-DNA librairies. Mol Cell Biol 1995 ; 15 . 704-10.
32. Morin PJ, Vogelstein B, Kinzler KW Apopotosis and APC in colorectal tumorigenesis Proc Natl Acad Sci USA 1996 ; 93 : 7950-4.
33. Satoh T, Nakafuku M, Kaziro Y. Function of ras as a molecular switch in signal transduction J Biol Chem 1992 , 267 : 24149-52.
34. Hall A. The cellular functions of small GTP-binding proteins. Science 1990 ; 249 635-40.
35. Feig LA The many roads that leads to Ras. Science 1993 ; 260 : 767-80.
36. Bollag G, McCormick F Regulators and effectors of ras proteins. Ann Rev Cell Biol 1993; 7 601-32
37. McCormick F. How receptors turn Ras on. Nature 1993 ; 363 : 15-6.
38. Barbacid M. Ras g précedait enes. Ann Rev Biochem 1987 , 56 : 779-827
39. Marshall CJ. How does p21ras transform cells. Trends Genet 1991 ; 7 : 91-5.
40. Tong L, de Vos AM, Milburn MV, Jancarik J, Noguchi S, Nishimura S, et al Structural differences between a ras oncogen protein and the normal protein. Nature 1989 ; 337: 90-3.
41. Minamoto T, Yamashita N, Ochiai A, Mai M, Sugimura T, Ronai Z, et al. Mutant K-ras in apparently normal mucosa of colorectal cancer patients. Its potential as a biomarker of colorectal tumorigenesis. Cancer 1995; 75: 1520-6.
42. Ronai Z, Luo FC, Gradia S, Hart WJ, Butler R. Detection of K-ras mutation in normal and malignant colonic tissues by an enriched PCR method. Int J Oncol 1994 ; 4 : 391-6.
43. Roncucci L, Pedroni M, Fante R, Di Gregorio C, Ponz de Leon M. Cell kinetic evaluation of human colonic aberrant crypts. (Colorectal Cancer Study Group of the University of Modena and the Health Care District 16, Modena, Italy.) Cancer Res 1993 ; 53: 3726-9.
44. Yamashita N, Minamoto T, Onda M, Esumi H. Increased cell proliferation of azoxymethane-induced aberrant crypt foci of rat colon. Jpn J Cancer Res 1994 ; 85 : 692-8.
45. Smith AJ, Stem HS, Penner M, Hay K, Mitri A, Bapat BV, et al. Somatic APC and K-ras codon 12 mutations in aberrant crypt foci from human colons. Cancer Res 1994 ; 54 : 5527-30.
46. Pretlow TP, Brasitus TA, Fulton NC, Cheyer C, Kaplan EL K-ras mutations in putative preneoplastic lesions in human colon J Natl Cancer Inst 1993 ; 85 : 2004-7.
47. Shpitz BHK, Medline A, Bruce WR, Bull SB, Galliger S, Stern H. Natural history of aberrant crypt foci. Dis Colon Rectum 1996; 39 763-7.
48. min and an activated ras mutation is sufficient to induce colon carcinoma. Mol Cell Biol 1996 ; 16 : 884-91.
49. Livingstone LR, White A, Sprouse J, Livanos E, Jacks T Altered cell cycle arrest and gene amplification potential accompany loss of wild type p53. Cell 1992 ; 70 : 923-35.
50. Yin Y, Tainsky MA, Bischoff FZ, Strong LC, Wahl GM. Wild type p53 restores cell cycle control and inhibits gene amplification in cells with mutant p53 alleles. Cell 1993 ; 70 : 937-48.
51. Bischoff FZ, Yim SO, Pothak S Grant G, Sicilano MJ, Giovanella BC, et al. Spontaneous abnormalities in noria fibroblasts from patients With Li-Fraumeni cancer syndrome : aneuploidy and immortalisation. Cancer Res 1990 , 50 . 7979-84.
52. Harvey M, Sands AT, Weiss RS, Hegi ME, Wiseman RW, Pantazis P, et al In vitro growth characteristics of the embryo fibroblasts isolated from p53 deficient mice. Oncogene 1993 ; 8 : 2457-67.
53. Carder PJ, Cripps KJ, Morris R, Collins S, White S, Bird CC, Wyllie AH. Mutation of the p53 gene precedes aneuploid clonal divergence in colorectol carcinoma. Br J Cancer 1995 ; 71 : 215-8.
54. Fearon ER, Cho KR, Nigro JM, Kern SE, Simons JW, Ruppert JM, et al Identification of a chromosome 18q gene that is altered in colorectal cancers, Science 1990; 247: 49-56.
55. Keino-Masu K, Masu M, Hinck L, Leonardo ED, Chan SS-C, Culotti JG, Tessier-Lavigne M. Deleted in colorectal cancer (DCC) encodes a netrin receptor Cell 1996; 87: 175-85.
56. Chan SS-Y, Zheng H, Su MW, Wilk R, Killeen MT, Hedgecock EM, Culotti JG. UNC-40, a C, elegans homolog of DCC (deleted in colorectal carcinoma cancer), is required in motile cells responding to UNC-6 netrin cues. Cell 1996 , 87 : 187-95.
57. Kolodziej PA, Timpe LC, Mitchell KJ, Fried SH, Goodman CS, Jan LY, Jan YN Frazzled encodes a drosophilia member of the DCC immunoglobulin subfamily and is required for CNS and motor axon guidance. Cell 1996 ; 87 : 197-204
58. Thiagalingam S, Lengauer C, Leach FS, Schutte M, Hahn SA Overhauver J, et al Evaluation of candidate tumor suppressor genes on chromosome 18 in colorectal cancer Nature Genet 1996 ; 13 : 343-6
59. Klingelhutz AJ, Hedrick L, Cho KR, McDougall JK. The DCC gene suppresses the malignant phenotype of transformed human epithelial cells Oncogene 1995 ; 10 . 1581-6.
60. Cho KR, Oliner JD, Simons JW, Hedrick L, Fearon ER, Preisinger AC, et al. The DCC gene : structural analysis and mutations in colorectal carcinomas. Genomics 1994 ; 19 : 525-31
61. Hahn SA, Schutte M, Hoque ATMS, Moskalluk CA, da Costa LT, Rozenblum E, et al. DPC4, a candidate tumor suppressor gene of human chromosome 18q21 1 Science 1996; 271 : 350-3.
62. Eppert K, Scherer SW, Ozcelik, Pirone R, Hoodless P, Kim H, et al. MADR2 to 18q21 and encodes a TGFβ-regulated MAD-related protein that is fuctionnally mutated in colorectal carcinoma. Cell 1996 ; 86 : 543-52.
63. Riggins GL, Thiagalingam S, Rozenblum E, Weinstein CL, Kern SE, Hamilton SR, et al. Mad-related genes in the human. Nature Genet 1996 ; 13 : 374-9.
64. Lagna G, Hata A, Hemmati-Brivatou A, Massague J. Partnership between DPC4 and SMAD proteins in TGFβ signalling pathways. Nature 1996 , 383 : 832-6.
65. Loeb LA. Mutator phenotype may be required for multistage carcinogeneis. Cancer 1991 ; 51 : 3075-9.
66. Bhattacharryya NP, Skandalis A, Ganesh A, Groden J, Meuth M. Mutator phenotype in human colorectal cell lines. Proc Natl Acad Sci USA 1994 , 91 : 6319-23.
67. Eshleman JR, Lang EZ, Bowerfind GK, Parsons R, Vogelstein B, Willson JK, et al. Increased mutation rate at the HPRT locus accompagnies microsatellite instability in colorectal cancer. Oncogene 1995 ; 10 . 33-7
68. Hemminki A, Peltomaki P, Mecklin J-K, Jarvinen H, Salovaara R, Nyström-Lahti M, et al. Loss of trie wild type MLH1 gene is a feature of hereditary nonpolyposis colorectal cancer. Nature Genet 1994 ; 405-10
69. Liu B, Parsons R, Papadopoulos N, Nicolaides NC, Lynch HT, Watson P, et al Analysis of mismatch repair genes in hereditary non-polyposis colorectal cancer patients. Nature Medicine 1996 ; 2: 169-74.
70. Parsons R, Myeroff LL, Liu J, Willson JKV, Markowitz SD, Kinzler KW, et al. Microsatellite instability and mutations of the transforming growth factor β type II receptor gene in colorectal cancer. Cancer Res 1995, 55 . 5548-50.
71. Markowitz S, Wang J, Myeroff L, Parsons R, Sun L, Lutter-Baugh J, et al. Inactivation of the type II TGF-beta receptor in colon cancer cells with microsatellite instability. Science 1995 ; 268 . 1336-8.
72. Lu S-L, Zhang W-C, Akiyama Y, Nomizu T, Yuasa Y Genomic structure of the transforming growth factor β type II receptor gene and its mutations in hereditary non polyposis colorectal cancers Cancer Res 1996 ; 56 . 4595-8.
73. Takenoshita S, Hagiwara K, Nagashima M, Gemma A, Bennet WP, Hariss CC. The genomic structure of the gene encoding the human transforming growth factor β type II receptor (TGF-β RII]. Genomics 1996; 36 : 341-4.
74. Souza RF, Appel R, Yin J, Wang S Smolinski KN, Abraham JM, Zou T-T, et al. Microsatellite instability in the insulin-like growth factor receptor gene in gastrointestinal tumours. Nature Genet 1996 , 14 : 255-7.